Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy (Q36080073)

12 August 2017

Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy (English)

1 reference

12 August 2017

1 reference

Vesalainen S

1

1 reference

12 August 2017

Nordling S

2

1 reference

12 August 2017

Lipponen P

3

1 reference

12 August 2017

Talja M

4

1 reference

12 August 2017

Syrjänen K

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 August 1994

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

70

1 reference

12 August 2017

2

1 reference

12 August 2017

309-314

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1994.298

12 August 2017

0 references

cites work

Consensus review of the clinical utility of DNA content cytometry in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

A computer program for comparing K samples with right-censored data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Flow cytometry of prostate cancer: relationship of DNA content to survival

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Ploidy level and tumor progression in prostatic carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

The epidemiology of prostatic cancer. Geographical distribution and time-trends

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Flow cytometry as a predictive modality in prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Nuclear deoxyribonucleic acid content measured by static cytometry: important prognostic association for patients with clinically localized prostate carcinoma treated by external beam radiotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Grading of prostatic carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Modal DNA-values in prostate cancer patients with deferred therapy or endocrine therapy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Value of Nuclear DNA Ploidy Patterns in Patients with Prostate Cancer after Radical Prostatectomy

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

The prognostic significance of ploidy and DNA-heterogeneity in the primary diagnosis and monitoring of patients with locally advanced prostatic carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Comparison of fresh and paraffin-embedded tissue as starting material for DNA flow cytometry and evaluation of intratumor heterogeneity

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Measurement of S-phase fractions in lymphoid tissue comparing fresh versus paraffin-embedded tissue and 4′,6′ -diamidino-2 phenylindole dihydrochloride versus propidium iodide staining

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033517

Histologic grading of primary prostatic cancer: a new approach to an old problem

21 October 2018

1 reference

12 December 2020

Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate

1 reference

12 December 2020

Modal DNA as prognostic indicator in untreated prostatic cancer

1 reference

12 December 2020

Intratumoral heterogeneity of DNA content in lung cancer

1 reference

12 December 2020

DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastases

1 reference

12 December 2020

DNA flow cytometry in carcinoma of the prostate for diagnosis, prognosis and study of tumor biology

1 reference

12 December 2020

DNA in radical prostatectomy specimens. Prognostic value of tumor ploidy

1 reference

12 December 2020

Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer

1 reference

12 December 2020

One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?

1 reference

12 December 2020

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

1 reference

12 December 2020

Prognostic significance of DNA quantitation in stage D1 prostate carcinoma with the use of image analysis

1 reference

12 December 2020

DNA ploidy in cell nuclei from paraffin-embedded material--comparison of results from two laboratories

1 reference

12 December 2020

The prognostic value of DNA content in patients with prostatic carcinoma

1 reference

12 December 2020

Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.298

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

8054280

1 reference